Primrose Bio

Join us at the Alliance for mRNA Medicines' (AMM) Ascent 1st Annual Meeting from November 13–15, 2024, at the Hilton Boston Park Plaza Hotel! Primrose Bio's Michele Rubino will be there to discuss our innovative solutions that enhance the manufacturability of therapeutic mRNA, including new modalities. Learn how our high-performing RNA polymerases (Prima RNApols) improve quality and reduce costs of mRNA manufacturing, unlocking the potential for previously non-manufacturable drugs. Work with us:?https://lnkd.in/gQxNV2mW #MRNAMedicines #BiotechInnovation #partneringONE #Biopharma #LifeSciences

Primrose Bio's Michele Rubino will be attending the International mRNA Health Conference from November 12–14 at the Hilton Boston Park Plaza Hotel. Connect with Michele to learn more about our mRNA manufacturing solutions. Our high-performing RNA polymerases (Prima RNApols) enhance mRNA quality and lower costs for a wide range of mRNA compounds in therapeutic and vaccine applications. Work with us: https://bit.ly/40C5dnD #mRNA2024 #mRNAHealthConference

Primrose Bio is at PEGS Europe, November 5-7, in Barcelona. Visit booth #1610 with any questions on our advanced production technologies for manufacturing complex protein and nucleic-acid therapeutics. Our business development team looks forward to connecting with you. #PEGSEurope #PrimroseBio

Join us at PEGS Europe on Nov 6 at 10AM to hear Diane Retallack, PhD's talk entitled "Streamlined Antibody and Therapeutic Development Using the Pfenex Expression Technology? Platform." Discover how our pioneering platform with a legacy of success and value creation is transforming the field! Learn more: https://bit.ly/4ftdr5E #PEGSEurope #PrimroseBio #PfenexExpressionTechnology

We're stirring up a potion of innovation every day to conjure boo-tiful results. Wishing you a Happy Halloween! ????

Meet with Primrose Bio and Intravacc at The World Vaccine Congress-EU in Barcelona next week! Together, we aim to revolutionize the landscape of conjugate vaccine development, ultimately benefiting millions worldwide. #Pelicrm197 #Intravacc #vaccines #crm197

Primrose Bio's Louis Cantolupo will attend The World Vaccine Congress EU in Barcelona from October 28-31, 2024. Reach out to schedule a meeting and learn more about our tools used to improve manufacturability of complex molecules used in protein and nucleic acid based vaccines: https://bit.ly/3BLQ093 #primrosebio #WVCEU #vaccines

CRM197 produced by the Pfenex Expression Technology continues to enable complex vaccines! #PrimroseBio #CRM197 #vaccines

Prima RNApols? are compatible with any DNA template sequence and length, facilitating the manufacturability of long mRNAs (>10 kb) for self-amplifying mRNA-based drugs, and achieving higher yields per DNA template unit. Work with us: https://bit.ly/3XTud85 #PrimroseBio #PrimaRNApols #mRNA #vaccines #therapeutics

Primrose Bio's innovative RNA polymerases, Prima RNApols?, surpass T7 RNA polymerase (T7 RNApol) across many metrics. T7 RNApol is known to be inefficient and generates unwanted double-stranded RNA (dsRNA) byproducts that may trigger adverse immune responses. Prima RNApols break these barriers by delivering higher mRNA yields, greater purity of target RNAs, and drastically reduced dsRNA levels. Discover more: https://bit.ly/3XBwofj #mRNA #vaccines #therapeutics #PrimaRNApols